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Background. Pediatric patients undergoing repair of congenital cardiac 
abnormalities have a significant risk of an adverse neurologic event. 
Therefore this retrospective cohort study examined the potential benefit 
of interventions based on intraoperative neurophysiologic monitoring in 
decreasing both postoperative neurologic sequelae and length of hospi- 
tal stay as a cost proxy. Methods: With informed parental consent 
approved by the institutional review board, electroencephalography, 
transcranial Doppler ultrasonic measurement of middle cerebral artery 
blood flow velocity, and transcranial near-infrared cerebral oximetry 
were monitored in 250 patients. An interventional gorithm was used to 
detect and correct specific deficiencies in cerebral perfusion or oxygen- 
ation or to increase cerebral tolerance to ischemia or hypoxia. Results: 
Noteworthy changes in brain perfusion or metabolism were observed in 
176 of 250 (70%) patients. Intervention that altered patient management 
was initially deemed appropriate in 130 of 176 (74%) patients with 
neurophysiologic changes. Obvious neurologic sequelae (i.e., seizure, 
movement, vision or speech disorder) occurred in five of 74 (7%) 
patients without noteworthy change, seven of 130 (6%) patients with 
intervention, and 12 of 46 (26%) patients without intervention (p = 
0.001). Survivors' median length of stay was 6 days in the no-change and 
intervention groups but 9 days in the no-intervention group. In addition, 
the percentage ofpatients in the no-intervention group discharged from 
the hospital within 1 week (32%) was significantly less than that in 
either the intervention (51%, p = 0.05) or no-change (58%, p = 0.01) 
groups. On the basis of an estimated hospital neurologic omplication 
cost of $1500 per day, break-even analysis justified a hospital expendi- 
ture for neurophysiologic monitoring of $2142 per case. Conclusions: 
Interventions based on neurophysiologic monitoring appear to decrease 
the incidence of postoperative n urologic sequelae and reduce the length 
of stay. Inasmuch as the break-even cost for neurophysiologic monitor- 
ing is more than four times the actual average charge, both patients and 
hospital may profit from this service. Because this study was not a truly 
randomized clinical trial, unintentional statistical bias may have oc- 
curred and caution is urged in interpreting the magnitude of apparent 
intergroup outcome differences. (J Thorac Cardiovasc Surg 1997;114:707-17) 
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O ver the past several years, our group has used multimodality neurophysiologic monitoring to 
identify the specific causes of neurologic injury 
associated with the diagnoses or surgical correction 
, . 1 
of cardiac dysfunction. We demonstrated the feb- 
able detection of cerebral ischemia by quantitative 
electroencephalography (EEG), transcranial Dopp- 
ler (TCD) ultrasonography, and cerebral oximetry 
during the testing of implantable cardioverter-defi- 
brillators. Additionally, our prospective controlled 
study 2showed the potential clinical value of detect- 
ing cerebral ischemia during myocardial revascular- 
ization. Monitored patients had a significantly lower 
incidence of postoperative disorientation. Recently, 
we 3 developed a neurophysiologic monitoring- 
based intervention algorithm to detect and correct 
sources of cerebral injury during cardiopulmonary 
bypass. The algorithm was initially successfully eval- 
uated in high-risk adult cardiac operations for repair 
of aortic aneurysms with the aid of deep hypother- 
mia and retrograde cerebral perfusion. 4 
The present report describes a retrospective ex- 
amination of the clinical and economic benefit of 
this algorithmic approach to neurologic protection. 
The examination focused on pediatric patients hav- 
ing cardiac operations, partly because of their high 
susceptibility to brain injury. 5 We 6 had previously 
demonstrated the feasibility of intraoperative neu- 
rophysiologic monitoring in these young patients. 
Methods 
Patients. From June 1995 through December 1996, 250 
pediatric patients underwent neurophysiologic monitoring 
during repair of congenital cardiac defects. Composition 
of the patient population is described in Table I. Essen- 
tially all patients undergoing cardiac surgery (open or 
closed) were monitored with the exception of those un- 
dergoing isolated closure of patent ductus arteriosus. This 
group was excluded because the extremely low incidence 
of neurologic omplications did not appear to justify the 
additional expense of neurophysiologic monitoring. 
Anesthetic and perfusion management. The standard- 
ized anesthetic protocol consisted of an opioid-midazolam 
infusionsupplemented by bolus administration of these 
agents when indicated. The unique aspects of perfusion 
management were the following. Cranial (i.e., tympanic) 
temperatur e was maintained at one of three levels, 34 ° , 
26°; 6r18 ° C, depending On the surgical requirements. The 
rare s' 0fc0o!ing and rewarming were standardized at 
0.3 ° C/min. The lovce:St acceptable sustained blood pres- 
sure was determined by neurophysioiogic monitoring, but 
in no cage v~as: it less than 30 mm Hg. Pump priming 
volumes were 650 mi for patients weighing less than 8 kg, 
850 ml for patients weighing 8 to 14 kg, and 1200 ml for 
those weighing more than 14 kg. Larger patientS had a 
nonblood prime (100 to 150 ml albumin 25%, electrolyte 
Table I. Age distribution of pediatric patients 
undergoing cardiac operations 
No change Intervention No intervention 
Age No. % No. % No. % 
<7 days 7 9 3 23 6 13 
8-30 days 8 11 6 5 1 2 
30 days-1 year 15 20 43 33 12 26 
1-5 years 19 26 27 21 15 33 
>5 years 25 34 24 18 12 26 
solution [Normosol-R], and mannitol 0.5 to 1 gm/kg). 
Infant prime also contained 1unit of fresh frozen plasma 
and 1 unit of packed red blood cells as needed to maintain 
a hematocrit value of 25%. Initial pump flow rates were 
set at 3.0 times the cardiac index for patients weighing less 
than 10 kg. Rates were changed proportionately in larger 
children to an ultimate value of 2.4 times the cardiac 
index. Alpha-stat acid-base management was used. On the 
basis of blood gas samples collected every 20 to 30 
minutes, fresh gas flow through the membrane oxygenator 
was adjusted to maintain arterial carbon dioxide tension 
near 35 mm Hg. A Terumo Capiox combination mem- 
brane oxygenator-venous reservoir (Terumo Medical 
Corp., Somerset, N.J.) was used in conjunction with a 
Gish 40 /xm arterial ine filter (Gish Biomedical, Inc., 
Irvine, Calif.). After periods of circulatory arrest, resump- 
tion of cold perfusion at the arrest temperature for 10 
minutes preceded rewarming. In cases involving circula- 
tory arrest, alpha-adrenergic blockade was used, which 
consisted of the administration of phentolamine 0.15 
mg/kg before the onset of bypass and again during re- 
warming. 
EEG. All neurophysiologic monitoring was performed 
by a dedicated technologist (H.L.E., V.S., G.N., A.S.). 
Cerebrocortical function was objectively characterized by 
using four-channel quantitative EEG. Cerebral biopoten- 
rials were recorded with gold cup electrodes placed at the 
Fpl-T3, Fp2-T4, C3-O1, and C4-O2 sites of the Interna- 
tional 10-20 electrode placement system. Fourier spectral 
analysis of the EEG (A-1000, Aspect Medical Systems, 
Natick Mass.; or Excel Signal Analyzer, Cadwell Labs, 
Kennewick, Wash.; or NeuroTrac II, Moberg Medical, 
Ambler, Pa.) produced simple numeric indices uitable for 
characterizing changes in the complex waveforms. Ampli- 
tude of the signal was determined by total power in 
picowatts or decibels in successive 2-second epochs. A 
suppressed EEG was defined as an amplitude of less than 
10 pW or 50 dB (i.e., signal-to-noise ratio of < 10:1) in 
more than 30% of epochs per minute. Excessive EEG 
slowing was defined as the relative delta (1.5 to 3.5 Hz) 
power band comprising more than 80% of the total power 
in the EEG signal. 
Cerebral blood flow velocity measurement. Flow 
through the righ t middle cerebral artery was verified 
continuously and noninvasively by TCD ultrasonography. 
A 2 MHz pulse-wave ultrasound transducer was fixed 
above the zygomatic arch with a commercially available 
soft rubber holder (Medasonics, Inc., Fremont, Calif.). 
This transducer insonated the portion of the middle 
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Table I I .  Intervention algorithm initiated by EEG slowing and~or cerebral venous oxygen desaturation 
Temp BP TCD Notification Intervention 
Prebypass 
0 0 -Peak velocity Aorta obstructed Adjust aortic cannula 
0 0 -Diastolic velocity Cava obstructed Adjust venous cannula 
Cardiopulmonary b pass 
0 0 ÷ Peak velocity Hyperemia -Pump flow 
0 0 Gas emboli Gas emboli Deair; repair circuit 
+ 0 Peak velocity Flow-metabolism uncoupling +BP; -Metabolic demand 
0 0 Peak Cerebral f ow low Adjust cannula/clamp; 
+Pump flow 
Postbypass 
0 0 -Diastolic velocity Cerebral edema Mannitol; Ultrafiltration 
Anytime 
0 - -Peak velocity Dysautoregulation + BP; neuroprotectant 
With + EEG frequency 
0 0,+ 0,+ peak velocity Insufficient anesthesia + Anesthesia 
0, No change; +, increase; , decrease; BP, blood pressure; TCD, transcranial Doppler; Temp, tympanic Ornasopharyngeal t mperature. 
cerebral artery near its juncture with the ipsilateral ante- 
rior cerebral artery: A color Fourier analyzer (Neuro- 
Guard, Medasonics) displayed the flow velocity spectral 
profile on a color monitor. Key spectral segments illus- 
trating changes in cerebral b lood flow velocity were also 
stored digitally and printed as black and white images. 
Cerebral blood flow velocity was quantified from the 
upper edge of the Velocity spectrum. A reversal Of flow 
direction was signified by spectral inversion. The criterion 
for a noteworthy decrease in peak flow velocity was an 
absolute value of 20 cm/sec for large children or a 50% 
reduction from baseline for neonates and infants. The 
baseline was established just before insertion of the aortic 
cannula. An excessively high peak velocity indicative of 
hyperemia was defined as a value twice the baseline that 
persisted for more than 3 minutes. The criterion for a low 
diastolic Velocity was a velocity below the level of detect- 
ability (i.e., 4 cm/sec with a 75 Hz low-pass filter). 
Regional cerebral venous oxygen saturation measure- 
ment. The adequacy of cerebral oxygenation was assessed 
with the use of relative changes in cerebrovenous oxygen 
saturation with transcranial near-infrared spectroscopy. A 
self-adhesive patch, containing an infrared light-emitting 
diode and two distant sensors (30 mm [scalp] and 40 mm 
[scalp plus brain]), was fixed on the left side of the 
patient's forehead. Cerebrovenous oxygen saturation was 
calculated from the differential signal obtained from these 
two sensors, expressed as the venous-weighted percent 
oxygenated hemoglobin. The cerebrovenous oxygen satu- 
ration trend was displayed on an infrared spectrophotom- 
eter (INVOS 3100A, Somanetics Corp., Troy, Mich.): A 
specially designed preamplifier attenuated the sensor out- 
put tenfold to prevent amplifier saturation by the high- 
amplitude Signals. The trend represented a temperature- 
corrected average of 16,5 seconds of data updated every 
3:3 seconds. Data points comprising the moving average 
trend were stored continuouSly on floppy disk every 30 
seconds. 
Desaturation signifying cerebral ischemia was defined 
as a regional cerebral venous oxygen saturation decrease 
of more than 20% of the baseline stablished just before 
aortic cannulation, which persisted for more than 3 min- 
utes. The 20% value had been determined empirically 
from our earlier study of the cerebral ischemia ssociated 
with implantable cardioverter-defibrillator testing in nor- 
mothermic unanesthetized a ults. 1
Each patient's head was rotated leftward to improve 
surgical exposure and central venous line access. After 
positioning, a metal shelf was placed just above the head 
to protect the face and airway. The head position and 
shelf made it nearly impossible to fix and adjust an 
ultrasound probe placed over the left temporal region. 
Thus, to ensure some monitoring of both cerebral hemi- 
spheres during hypotherrnic suppression of EEG activity, 
we placed the oximeter sensor on the left side of the 
forehead. 
NeurophySi01ogic monitoring algorithm. The goals of 
neurophysiologic monitoring were to detect potential 
problems in patient management and to assess response 
to intervention. Specific problems fell primarily into one 
of three general areas: (1) abnormalities in cerebral 
perfusion, (2) cerebral venous oxygen desaturation, and 
(3) insufficient anesthetic depth. The algorithm for inter- 
vention, which was previously developed for use in adult 
cardiac surgery, 3 is summarized in Table II. The same 
intervention criteria were used in all cases. Detection of a 
perfusion abnormality was based on TCD evidence of low 
or absent flow velocity coupled with an EEG indication of 
synaptic depression or a cerebrovenous oxygen desatura- 
tion, or both. In the second group a noteworthy decrease 
in cerebral venous oxygen saturation occurred without a 
noteworthy change in TCD flow velocity. With inadequate 
anesthetic delivery, signs of increased synaptic activity and 
TCD flow velocity were coupled with a decreasing cere- 
brovenous oxygen saturation resulting from enhanced 
neuronal metabolic activity. In some cases, if adjustments 
in patient management failed to correct deficient perfu- 
sion or oxygenation, europrotectants were administered 
in the hope of increasing the brain's tolerance to ischemia/ 
hypoxia. The neuroprotectant combination was phenytoin 
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Table I I I .  Number of primary potential problems 
detected by neurophysiologic monitoring 
No 
Problem Intervention i tervention 
Perfusion imbalance 
Peak flow velocity high (hyperemia) 3 0 
Peak velocity low (aortic obstruction; 28 6 
low pump flow or pressure) 
Doppler signal absent (no cerebral 2 0 
ftow) 
Diastolic velocity low (venous 4 4 
obstruction; edema) 
Gas emboli 12 6 
Cerebral venous oxygen desaturation 
Airway obstruction 1 0 
Hemoglobin low 3 2 
Fioa low 5 0 
Carbon dioxide low 1 0 
Arterial pressure or pump flow low i8 41" 
Cerebral hypermetabolism with 10 117 
rewarming 
Cardiac output low 2 3 
Insufficient anesthetic depth 
EEG frequency increase 6 2 
Insufficient cooling 
EEG activity with deep hypothermia 1 0 
Fio~ Inspired oxygen fraction. 
*p < 0.001 compared by differences in proportions. 
tp < 0.05 compared by differences in proportions. 
15 mg/kg and dexamethasone 0,15 mg/kg. Because the 
propylene glycol-solubilized phenytoin formulation may 
induce cardiac dysfunction and profound hypotension, it 
was administered only as a last resort in hemodynamically 
stable patients. The Specific problems detected and asso- 
ciated interventions are shown in Tables I i! and IV. 
Postoperative care. Postoperative sedation for all pa- 
tients was standardized under the direction of a single 
surgeon (E.H.A.). It included a fentanyl infusion supple- 
mented with bolus doses of midazolam when indicated. 
Routine neurologic assessments were performed aily by 
the neonatal or pediatric intensivists. Suspected neuro- 
logic events were confirmed subsequently by a pediatric 
neurologist (M.K.S.) and the adverse outcomes were 
documented for inclusion in our database by cardiac nurse 
clinicians (C.D.C., K.M.C.). 
Study design and statistical analysis. Neurophysiologic 
monitoring technologists recorded the following physio- 
logic measures every 5 minutes throughout each case in a 
computerized spreadsheet: mean arterial pressure, central 
venous pressure, end-tidal anesthetic concentration, tym- 
panic temperature, cerebral venous oxygen saturation, the 
EEG parameters of relative delta power and burst-sup- 
pression ratio, the minimum, mean, and maximum middle 
cerebral artery flow velocities, and the Cumulative cerebral 
microemboli count. In addition, a 100-field computerized 
database of relevant demographic, diagnostic, intraoper- 
ative, and postoperative data was maintained on all pedi- 
atric patients undergoing cardiac operations. These two 
Table IV. Interventions guided by neurophysiologic 
monitoring 
No. of 
Intervention cases 
Perfusion imbalance 
Correct mechanical obstruction 
Aortic cannula reposition 22 
Venous cannula reposition 3 
Vascular clamp reposition 3 
Additional deairing; repair air leak 7 
Pump flow increase 15 
Pump flow decrease 3 
Plasma volume expansion 4 
Return to cardiopulmonary support 6 
Blood pressure increase 29 
Carbon dioxide increase 2 
Deficient oxygenation 
Increase Fio2 5 
Transfuse whole blood 3 
Reintubate 1 
Insufficient anesthetic depth 
Increase anesthetic delivery 8 
Limited ischemia tolerance 
Neuroprotectant 18 
Additional cooling 1 
digital records formed the basis of the retrospective 
review. To limit the database to a manageable size, we 
recorded only the most significant monitoring event and 
response. 
The application of multimodality neurophysiologic 
monitoring began primarily as an observational study 
without the intention to intervene with every noteworthy 
change. As experience accrued and the surgical team 
analyzed the cumulative database results, the value of 
responding to neurophysiologic monitoring detections be- 
came increasingly apparent. After several of these interim 
analyses, most noteworthy changes were followed with an 
appropriate intervention (Fig. 1). As such, the total group 
of patient s could be divided into three cohorts based on 
the presence or absence of a noteworthy neurophysiologic 
change (i.e., notification and no change) and the response 
of the surgical team to the notification (i.e., intervention 
and no intervention). This design allowed us to examine 
the consequences of neurophysiologic change versus no 
change and intervention versus no intervention. 
The central tendency and dispersion of Gaussian inter- 
val data were described by the mean and 95% confidence 
interval, and the median and interquartile ranges were 
used for non-Gaussian data. Ordinal (scalar) values and 
non-Gaussian i terval data were expressed as proportions 
or odds ratios (i.e., percent affected with 95% confidence 
intervals). The confidence intervals for binomial propor- 
tions were calculated with the aid of personal computer- 
based StatXact software (Cytel Software, Cambridge, 
Mass.). Unless otherwise indicated, all numbers in paren- 
thesis signify 95% confidence intervals. 
Financial decisions profoundly affecting health care are 
often not based on statistical comparisons commonplace 
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Fig. 1. Time line of cases in which noteworthy neurophysiologic monitoring changes were observed. As 
experience accrued, virtually all noteworthy detections resulted in an intervention. 
in scientific literature. That is, statistical and financial 
significance are not necessarily synonymous or related. 
Therefore aconventional break-even analysis was used to 
determine the revenue-neutral hospital expenditure for 
neurophysiologic monitoring justified by the reduced rate 
of neurologic omplications and decreased length of stay. 
The hospital's daily cost for a neurologic omplication or 
prolonged stay was estimated to be $1500 per day. 
Results 
Patient characteristics. The clinical characteris- 
tics of the three groups are summarized in Tables I 
and V. There were no marked intergroup differ- 
ences in age distribution or primary surgical proce- 
dure. The distribution of neurophysiologic monitor- 
ing notifications was similar in both the intervention 
and no-intervention groups (Fig. 2). The TCD and 
cerebral oximetric criteria for deterioration were 
established with the use of baseline reference values 
obtained just before aortic cannulation. Thus the 
criteria were dependent, in part, on the cerebral 
state at that moment. Therefore intergroup compar- 
isons of several physiologic measures were made to 
detect evidence of unintentional statistical bias re- 
suiting from nonrandom group assignment. Group 
mean and 95% confidence intervals for the no- 
change, intervention, and no-intervention groups, 
respectively, were as follows: mean arterial pressure, 
58 mm Hg (54 to 61 mm Hg), 54 mm Hg (46 to 54 
mm Hg), and 52 mm Hg (45 to 58 mm Hg); 
end-tidal carbon dioxide, 29 mm Hg (27 to 31 mm 
Table V. Distribution of surgical procedures and 
neurologic sequelae 
No No 
Procedure change Intervention intervention 
Aortic arch repair 4 
Aortic stenosis repair 11 2 
Arterial switch 3 4 1 
ASD closure 12 12 5 
AV canal repair 2 8 3 
Valve repair/replacement 3 4 2 
Blalock-Taussig shunt 3 9 2 
Coarctation of aorta 10 9 2 
DORV repair 2 
Fontan 1 3 2 
Glenn shunt (bidirectional) 3 6 3 
Miscellaneous 12 2 1 
Myectomy 2 1 
Norwood 9 2 
Pul stenosis/atresia repair 1 11 
PAPVR or TAPVR repair 2 4 3 
Rastelli 1 1 
Ross 6 6 2 
Tetralogy of Fallot repair 3 4 4 
Truncus arteriosis repair 2 i 
Transplant, cardiac 1 1 
VSD repair 10 19 1 
TOTAL 74 130 46 
Neurologic sequelae 5 7 12 
Deaths 5 8 17 
ASD, Atrial septal defect; A~ atrioventricular; DORV, double-outlet right 
ventricle; PAPVR, TAPVR, partial or total anomalous pulmonary venous 
return; VSD, ventricular septal defect. 
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Fig. 2. Distribution of type of neurophysiologic monitoring change observed in the intervention and 
no-intervention groups. 
Hg), 30 mm Hg (28 to 32 mm Hg), and 31 mm Hg 
(28 to 34 mm Hg); tympanic temperature, 35 ° (34 ° to 
36°), 35 ° (35 ° to 36°), and 35 ° (34 ° to 36°). In the 
absence of significant intergroup differences, no 
evidence of bias was found. 
Neurophysiologic monitoring data. A notewor- 
thy change was detected in 176 (70%) of the 250 
patients studied. Table III lists the specific problems 
detected by neurophysiologic monitoring. Perfusion 
imbalance comprised 37% of the total number of 
problems detected. An abnormal pattern of cerebral 
perfusion was initially detected by TCD and the 
clinical impact of the change was assessed by cere- 
bral oximetry or EEG, or both. Thus flow was 
determined tobe low enough to warrant adjustment 
only if it was associated with depression of synaptic 
activity or cerebral venous oxygen desaturation. 
Similarly, because the TCD is exquisitely sensitive to 
the presence of even minute amounts of gas bub- 
bles, notification of clinically important emboli ne- 
cessitated concomitant change in cerebral oximetry 
or EEG, or both. 
Cerebral venous oxygen desaturation was by far 
the most common source for intervention. Marked 
desaturation in excess of 20% of the precannulation 
baseline was the basis for 58% of the notifications. 
In most cases, EEG slowing eventually accompanied 
evidence of desaturation, although decreasing val- 
ues on the oximeter nearly always preceded electro- 
graphic signs of depressed synaptic activity. 
Only infrequently were signs of insufficient anes- 
thetic depth observed. Cerebral venous oxygen de- 
saturation, signifying an increased metabolic de- 
mand coupled with an increasing EEG mean 
frequency and/or loss of low-frequency delta activ- 
ity, occurred in only 5% of the notifications. 
Table IV lists the cases in which interventions 
were made in response to problems detected by 
neurophysiologic monitoring. The surgeon, anesthe- 
siologist, and perfusionist were all involved in mak- 
ing adjustments o potential problems detected by 
neurophysiologic monitoring. The surgeon was di- 
rectly involved in 27% of the 130 interventions made 
in patient management. These activities involved 
repositioning of the aortic or venous perfusion 
cannulas or a vascular clamp. Additionally, TCD- 
detected gas microemboli prompted further deair- 
ing measures in seven patients. 
The perfusionist was involved in 52% of the 
adjustments. The TCD and cerebral oximeter made 
it clear that seemingly small changes in pump flow 
or perfusion pressure may have profound conse- 
quences for effective cerebral perfusion. For exam- 
ple, during low-flow bypass, a sudden further drop in 
pump flow of as little as 200 ml/min occasionally 
resulted in a near-cessation f cerebral perfusion 
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and profound desaturation, despite a drop in sys- 
temic perfusion pressure of less than 5 mm Hg. 
The remaining 21% of interventions, made by the 
anesthesiologist, varied widely in nature from cor- 
rection of airway problems to increasing anesthetic 
depth. Neuroprotectant doses of phenytoin and 
dexamethasone w re administered to 10 patients in 
hemodynamically stable condition, when more con- 
ventional and conservative adjustments alone failed 
to correct the imbalance in cerebral homeostasis 
detected through neurophysiologic monitoring. 
There was no clear relationship between the failure 
to respond to conventional intervention and the type 
of surgical procedure, which included repair of atrial 
and ventricular septal defects, mitral valve replace- 
ments, repair of tetralogy of Fallot, and repair of 
pulmonary stenosis or atresia. 
Postoperative outcome results. Neurologic out- 
come in the three groups is shown in Table VI. 
There was no difference in incidence of neuro- 
logic sequelae between the no-change (7%) and 
the intervention (6%) groups. However, the inci- 
dence in the no-intervention group (26%) was 
significantly (p -- 0.003) higher. Similarly, the 
median length of stay in the no-intervention group 
was 3 days longer than in the other two groups, 
although this difference did not reach statistical 
significance because of the high variance within 
each group. However, the proportion of no-inter- 
vention patients discharged from the hospital 
within 1 week (32%) was significantly lower than 
that observed in either the intervention (51%, p = 
0.05) or no-change (58%, p = 0.01) groups. The 
small sample size of phenytoin-treated patients 
precluded reliable determination of the drug's 
effect on awakening time or duration of postop- 
erative mechanical ventilation. 
Use of the three study cohorts permitted calcula- 
tion of the incidence of noteworthy neurophysio- 
logic change and the probabilities that such a change 
would result in a prolonged hospital stay in the 
presence and absence of neurophysiologic monitor- 
ing. The break-even cost was $2142 per case, or 
more than four times the monitoring charges. 
Discussion 
During cardiopulmonary b pass, the critical bal- 
ance between the delivery of oxygenated blood and 
the brain's metabolic demand for it is importantly 
influenced by a wide range of variables under the 
direct control of the surgical team. Historically, 
management of these variables has been by empir- 
Table VI. Effect of neurophysiologic monitoring on 
neurologic omplication and length of hospital stay 
No No 
change Intervention intervention 
Neurocomplication 5/74 (7%) 7/130 (6%) 12/46" (26%) 
Seizure 3 5 5 
Cerebral infarct 1 3 
Chorea 1 1 1 
Visual neglect 1 
Hypotonia 1 2 
Speech disorder 1 
Length of stay: median 6 (4-12) 6 (5-12) 9 (5-13)? 
(interquartile range) 
Percent discharged 58 51 32:~ 
< 7 days 
*p = 0.003 versus intervention; p = 0.01 versus no change. 
?Median (interquartile range); no significant intergroup differences. 
~;p = 0.05 versus intervention; p = 0.01 versus no change. 
ically derived protocol. In the absence of informa- 
tive feedback from the patient's brain, individual 
teams rely on standard protocol for most patients. 
This relatively uniform approach to perfusion man- 
agement may thus lead to an injurious oxygenation 
imbalance, particularly in the immature brains of 
critically ill infants with complex cardiovascular 
anomalies. 
Neurophysiologic monitoring offers an alternative 
method to management of cardiopulmonary sup- 
port in which each of the variables may be individ- 
ualized and quickly adjusted to address changes in 
oxygen supply-demand balance. Because the brain 
has the highest blood flow and metabolic demand of 
any vital organ, it provides the ideal site for assess- 
ing the match between perfusion and oxygenation. 
The multimodality approach to neurophysiologic 
monitoring assures that the team has direct contin- 
uous information about the status of cerebral oxy- 
gen delivery and consumption under all circum- 
stances, even deep hypothermic circulatory arrest. 
EEG monitoring has been used successfully to 
detect cerebral ischemia since the earliest days of 
cardiac surgery] However, it has not achieved wide- 
spread acceptance by cardiac surgeons or anesthe- 
siologists, although there is a growing concern about 
the neurologic and cognitive deterioration that may 
result from cardiopulmonary b pass. Aside from the 
complexity of conventional EEG analysis and its 
susceptibility to electrical and mechanical artifact, 
its value is often questioned because of poor speci- 
ficity. 8 The EEG is unquestionably very sensitive in 
detecting regional synaptic depression accompany- 
ing cerebral ischemia or hypoxia. Unfortunately, 
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many noninjurious processes may produce the same 
EEG changes as hypoperfusion or hypoxia. 
Our approach as been to use additional moni- 
toring modalities and an algorithm to improve spec- 
ificity and consistency. The cerebral oximeter has 
proved invaluable because of its ability to distinguish 
between EEG slowing caused by ischemia versus 
that resulting from excessive anesthesia. In the 
former, inadequate oxygen delivery causes ynaptic 
depression and cerebral venous oxygen desatura- 
tion; in the latter, anesthetic depression of synaptic 
function slows the EEG but increases oxygen satu- 
ration because of decreased metabolic demand. The 
oximeter also aids ischemia detection when the 
EEG is uninterpretable or absent because of arti- 
facts, high-dose anesthesia, or deep hypothermia. 
Although near-infrared spectroscopy is a promis- 
ing new technology, the current commercial devices 
have practical and theoretical limitations. On the 
practical side, none have been cleared by the U.S. 
Food and Drug Administration for pediatric use. 
Therefore application of this technology requires 
informed parental consent sanctioned by the insti- 
tutional review board. On the theoretical side, some 
of the devices, like the Somanetics INVOS 3100-A 
spectrophotometer used in the present study, mea- 
sure only intravascular hemoglobin saturation. Be- 
cause a number of physiologic perturbations occur- 
ring during hypothermic ardiopulmonary bypass 
may alter the hemoglobin dissociation curve, the 
oxygen saturation values do not directly indicate the 
amount of oxygen actually available to neurons. 
Some of these devices claim to measure cytochrome 
a-a3, which may provide a direct indication of oxy- 
genation within neuronal mitochondria. Finally, the 
INVOS spectrophotometer quantified the magni- 
tude of change from a baseline established before 
aortic cannulation, rather than providing absolute 
oxygen saturation. The lack of an absolute criterion 
for cerebral hypoxia complicates the intervention 
algorithm and may lead to uncertainty. 
A wide range of perfusion abnormalities can be 
detected promptly and unambiguously with TCD. 
Flow patterns can distinguish between aortic and 
caval obstructions, even though both may eventually 
produce EEG slowing or desaturation. Hyperflow 
velocity patterns with no accompanying EEG abnor- 
mality but a potential for intracerebral hemorrhage 
can be quickly detected and corrected. The hyper- 
emia is accompanied by an elevated cerebral venous 
oxygen saturation. 
The present study used alpha-stat acid-base man- 
agement, but many centers now prefer pH-stat or a 
mixture of both alpha-stat and pH-stat. Because 
cerebral blood flow velocity is normally exquisitely 
sensitive to change in arterial carbon dioxide, the 
ultrasonic intervention criteria for hypoperfusion 
and hyperperfusion may have to be adjusted to 
reflect differing acid-base strategies. 
Neuroprotection was an attempt o increase the 
brain's tolerance to a persistent imbalance between 
oxygen supply and demand. When the EEG or 
cerebral oximeter failed to respond to conventional 
measures such as increased inspired oxygen fraction 
or perfusion pressure, dexamethasone and phenyt- 
oin were administered to hemodynamically stable 
patients. Dexamethasone was used because of the 
membrane-stabilizing and neuroprotectant proper- 
ties of corticosteroids. 9 In contrast, phenytoin 
served as a sodium channel modulator to prevent 
accumulation of cytotoxic intracellular concentra- 
tions of sodium, l° The antiischemic and antihypoxic 
properties of phenytoin have been demonstrated in 
a wide variety of animal models, 11-16 and fosphenyt- 
oin is currently under clinical investigation in the 
treatment of stroke. Neuroprotectant administra- 
tion has become a more attractive option with the 
advent of the water-soluble and cardiovascularly 
benign fosphenytoin. 17 
Results of this pilot retrospective examination of 
the value of neurophysiologic monitoring raise both 
practical and ethical questions regarding the appro- 
priateness of subsequent prospective, randomized, 
controlled studies. Reduction in the neurocomplica- 
tion rate was achieved by a multistage process or 
algorithm that depended on EEG, TCD, cerebral 
oximetry, and a list of appropriate corrective ac- 
tions. No one device or action alone can hope to 
achieve comparable results. Prospective, random- 
ized, controlled evaluation of the entire process 
appears to represent a daunting challenge in exper- 
imental design. The benefit of most of the corrective 
actions is self-evident, such as cannula adjustment 
or pump flow increase to improve cerebral perfu- 
sion. However, the role of neuroprotectants per se is 
less certain. A prospective valuation of the actual 
benefit of phenytoin, dexamethasone, and other 
candidate neuroprotectants seems essential before 
their widespread adoption. 
Regarding the ethical issue, TCD ultrasonogra- 
phy and cerebral oximetry provide direct continuous 
measurement of cerebral perfusion and oxygen- 
ation. A sudden precipitous coincident decline in 
these measures provides a clear indication of cere- 
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bral hypoxia and its cause. To knowingly detect his 
obvious deficiency and not attempt o correct the 
underlying problem in the name of scientific rigor 
appears to us to be both unethical and unconscionable. 
However, the informational value of some other neu- 
romonitoring data, that is, inadequate l vel of anes- 
thesia, is not as well established and could benefit from 
prospective randomized evaluation. 
In retrosPective Cohort studies, the value of com- 
parative inferential statistics is often limited by lack 
of true randomization and imbalance in patient 
assignment. This limitation applies to the current 
study, since as an account of our initial experience 
with an intervention algorithm guided by neurophys- 
iologic monitoring it was not a truly randomized 
clinical trial. This inadequacy may have resulted in 
unintentional statistical bias, and caution is urged in 
interpreting the magnitude of apparent intergroup 
outcome differences, 
Despite the potential design limitations of this study, 
its results suggest that the neurophysiologic monitoring 
algorithm can help to improve neurologic outcome in a 
cost-effective manner. Determination feconomic bene- 
fit in many health care situations is complex, because 
economic benefit cannot be defined in unambiguous 
absolute terms. For example, the perceived cost of a 
postoperative n urologic omplication may vary consid- 
erably, depending on the identity of the payor (i.e., 
insurer vs hospital vs patient) and reimbursement mech- 
anism. Complication cost will be viewed by hospital 
administrators a  the highest in reimbursement environ- 
ments characterized by capitated payments or a poorly 
insured patient population: Therefore the magnitude of 
the favorable cost savings for neurophysiologic monitor- 
ing will undoubtedly vary widely depending on viewpoint. 
However, the clinical benefit of neurophysiologic moni- 
toring--a significant reduction in neurologic sequelae-- 
is clear and independent of the vagaries of current health 
care economics. 
REFERENCES 
1. Singer I, Edmonds HL. Changes in cerebral perfusion during 
third-generation implantable cardioverter-defibrillator test- 
ing. Am Heart J 1994;127:1052-7. 
2. Edmonds HL Jr, Griffiths LK, van der Laken J, et al: 
Quantitative lectroencephalographic monitoring during 
myocardial revascularization predicts postoperative disorien- 
tation and improves outcome. J Thorac Cardiovasc Surg 
1992;103:555-563. 
3. Edmonds HL Jr, Rodriguez RA, Audenaert SM, et al. The 
role of neuromonitoring i  cardiovascular surgery. J Cardio- 
thorac Vasc Anesth 1996;10:15-23. 
4. Ganzel BL, Edmonds HL Jr, Pank JR. Neurophysiologic 
monitoring to assure delivery of retrograde cerebral perfu- 
sion. J Thorac Cardiovasc Surg. In press. 
5. Ferry PC. Neurologic sequelae of open-heart surgery in 
children. Am J Dis Child 1990;144:369-73. 
6. Rodriguez RA, Audenaert SM, Austin EH III, et al. Audi- 
tory evoked responses in children during hypothermic car= 
diopulmonary b pass. Clin Neurophysiol 1995;12:168-76. 
7. Theye RA, Patrick RT, Kirklin JW. The electro-encephaio- 
gram in patients undergoing open intracardiac operations 
with the aid of extracorporeal circulation. J Thorac Surg 
1957;34:709-17. 
8. Witoszka MM, Tamura H, Indeglia R, et al. Electroencepha- 
lographic hanges and cerebral complications in open-heart 
surgery. J Thorac Cardiovasc Surg 1973;66:855-64. 
9. Bracken MD, Shepard MJ, Collins WF. A randomized, 
controlled trial of methylprednisolone or naloxine in the 
treatment of acute spinal cord injury. N Engl J Med 1990; 
322:1405-11. 
Taylor CP. Na ÷ currents that fail to inactivate. Trends 
Neurol Sci (TINS) 1993;16:455-60. 
Wohns RNW, Kerstein MD. The role of dilantin in the 
prevention of pulmonary edema associated with cerebral 
hypoxia. Crit Care Med i982;10:436-43. 
12. Fukuda A, Tabuse H, Ihara N, et al. Effects of phenytoin on 
regional cerebral blood flow, electroencephalogram and elec- 
trolyte Contents in cerebral blood and cerebral cortex follow- 
ing total cerebral ischemia in dogs. Circ Shock 1983;10:341- 
50. 
13. Hayakawa T, Hamada Y, Maihara T, et al. Phenytoin reduces 
neonatal hypoxic-ischemic brain damage in rats. Life Sci 
1994;54:387-92. 
14. Taft WC, Clifton GL, Blair RE, et al. Phenytoin protects 
against ischemia-produced neuronal cell death. Brain Res 
1989;483:143-8. 
15. Imaizum! S, Suzuki J, Kinouchi H, et al. Superior protective 
effects of phenytoin against hyp0xia in a pharmacological 
screening test. Neurol Res 1988;10:18-24. 
16. Edmonds HL Jr, Jiang YD, Zhang PY, et al. Anticonvulsant 
activity of t0piramate and phenyt0in in a rat model of 
ischemia-induced epilepsy. Life Sci 1996;59:PL127-31. 
17. Ramsay RE, DeToledo J: Intravenous administration of
fosphenytoin. Neurology 1996;46(Suppl 1):$17-19. 
Discussion 
Dr. Richard A. Jonas (Boston, Mass.). I congratulate 
Dr. Austin and Dr. Edmonds and their coauthors on 
another very important contribution i  the area of neuro- 
physiologic monitoring during pediatric Cardiac surgery. 
Many controversies exist in tile management of cardio- 
pulmonary bypass, deep hypothermia, and the use Of 
circulatory arrest, including in particular perfusion vari- 
ables, such as optimal hematocrit and optimal pH strat- 
egy. The reason for these ongoing controversies i that 
there is no single on-line method to confirm tfiat oxygen 
delivery has been maintained to cerebral neurons 
throughout the brain. Surrogate nd points, Such as mixed 
venous oxygen saturation in the Venous cannula and the 
absence of a metabolic acidosis, are highly insensitive 
methods for determining that brain oxygenation is ade- 
quate. In this paper, the authors have used a combination 
of brain monitoring modalities and have described an 
algorithm to determine appropriate interventions. In their 
10. 
11. 
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retrospective nonrandomized analysis they have found 
that patients who were monitored and who had interven- 
tions were less likely to have postoperative neurologic 
complications. 
One of the main difficulties with the report, as Dr. 
Austin has pointed out, is the fact that patients were not 
randomized to an intervention versus nonintervention 
strategy. It would be helpful Dr. Austin, if you could 
further expand for us how decisions were made in the 
operating room as to when an intervention should be 
undertaken on the basis of these neurophysiol0gic moni- 
toring changes. Is it possible that the method of selection 
in some way biased the result? 
Second, I note that the near-infrared spectroscopy 
system that you Used was the Somanetics ystem, which 
measures only cerebral oxygenation. We have had consid- 
erable experience with the Hamamatsu instrument 
(Hamamatsu Corp., Bridgewater, N.J.), which measures 
not only cerebral oxygenation but also the relative redox 
state of cytochrome aa3. With hemodilution, hypother- 
mia, and with an alkaline pH strategy, such as alpha-stat, 
we believe that cerebral tissue oxygen status is less useful 
than cytochrome redox state because there may be inad- 
equate oxygen availability despite adequate levels of he- 
moglobin saturation. Do you have any experience with 
near-infrared spectroscopy that assesses cytochrome, and 
how does this influence your algorithm? 
Once again, I would like to congratulate he authors on 
an eXceedingly important contribution. Both Subtle and 
devastating neurologic injuries continue tO be important 
problems in children undergoing heart surgery. It will only 
be through refinement of on-line monitoring techniques 
such as those described by Dr. Austin and his group that 
we will be able to make serious inroads into this important 
problem. 
Dr. Austin. Thank you, Dr. Jonas. ! th~nk you clearly 
pointed out the difficulties with this study. As I reviewed 
the data and put together the presentation, I had similar 
concerns. Before embarking on this study I did not have 
many concerns about neurologic problems. As surgeons, 
we know that some seizures occur and that occasionally a 
child has a major neurologic problem. However, until I 
looked closely, I did not realize how significant the 
problem was. When Dr. Edmonds presented the oppor- 
tunity to examine what goes on during cardiopulmonary 
bypass in patients undergoing pediatric heart surgery, I
was certainly agreeable, we started this study simply to 
observe what happened in patients undergoing a variety of 
congenital heart repairs. This included some patients who 
had closed procedures, such as coarctation repairs and 
shunts. I must say that I was impressed with the number of 
abnormalities that we detected. Of course, at the begin- 
ning we did not really know how to respond. As I 
indicated in my presentation, there were some cases in 
which I just believed we had to respond. If when you start 
bypass the cerebral flow drops, the EEG changes, and 
there is a significant drop in oximetry, you feel obliged to 
do something. Cleaily in those cases that I mentioned, 
something was done. On the other hand, there are more 
subtle situations uch as when you are rewarming from 
bypass and the oximetry drops. Usually everything else 
seems to be acceptable, and if you were not monitoring, 
you would not do anything. Early in our experience we did 
not do anything, and, quite honestly, it is hard determine 
at what particular point we decided to change. Much of 
what was done was not even decided by the surgeon; itwas 
decided by the anesthesiologist working with the perfu- 
sionist deciding whether to increase pump flow or increase 
the arterial pressure with a vasoconstrictor. Usually when 
those changes were made, the oximetry would return 
toward baseline. I recognize that our approach to inter- 
vention may have introduced some bias with this study, 
and I think it warrants proceeding with further studies 
done in a more randomized fashion to verify our findings. 
However, we would have to select certain patients for the 
randomized approach, because I would find it unethical 
not to intervene in those cases in which there was a 
clear-cut change associated With a clear-cut change in the 
EEG. 
We have no experience with the device that you are 
using, which indicates cytochrome redox state. I am 
dependent on what Dr. Edmonds, my associate, provides, 
and we have not applied the device that you have men- 
tioned. All of this experience was derived with the use of 
the Somanetics system. 
For appendix see next page. 
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Appendix 
Neuromonitoring break-even analysis* 
Model parameters: 
P1 = Probability of complication in monitored patient 
P2 = Unmonitored 
C1 = Monitoring cost/case 
C2 = Intensive care unit complication cost/day 
V = Annual case volume 
X = Cost of uncontrollable complication (i.e., no monitored changes) 
Monitoring scenario cost." 
M = C1V + X + P1 (6C2)Vwith P1 = (7/130)(176/250) = 0.038 
M = X + V(C~ + 0.03816C2]) 
M = X + V(C1 + 0.228C2) 
Unmonitored scenario cost: 
U = X + P2(9C2)VwithP2 = (12/46)(176/250) = 0.184 
U = X + V (0.184 [9C2]) 
U = X + V (1.656 C2) 
Break-even point." 
M=U 
X Jr- V (C 1 q- 0.228 C2) = X ~- g (1.656 C2) 
V (C1 + 0.228 C2) = V (1.656 C2) with V > 0, C1 + 0.228 C 2 = 1.656 C2 
C1 + 1.428 C2 at C2 = $1500, C1 = $2142 
*Reinhardt UE. Break-even analysis for Lockheed's Tri-Star: an application of financial theory. J Finance 1973;28:821-8. 
